(Reuters) - "Investigators in these trials have hit their mark soundly: the vaccine showed significant efficacy against anogenital and cervical lesions," Dr. George Sawaya and Dr. Karen Smith-McCune of the University of California, San Francisco, wrote in a commentary in the New England Journal of Medicine, where the studies appear. "The vaccine also appears safe."
) Keywords: MERCK GARDASIL/
Read more at Reuters.com Government Filings News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment